Evaluation of aromatherapy in palliative care

Not Applicable

• Conditions: R45.1; Restlessness and agitation

• Registration Number: DRKS00017411
• Lead Sponsor: Interdisziplinäre Schmerz- und Palliativstation Klinik für Anästhesiologie und Operative Intensivmedizin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-05-28
• Study Completion: 2020-08-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

a) give their consent,
b) have a sense of smelling,
c) are in a single room.

Exclusion Criteria

a) no consent,
b) allergies to the fragrances or essential oils,
c) no smelling ability (tracheal cannula, runny nose, etc.),
d) no life-limiting illness, or
e) other (foreign language, no caregiver etc.).

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in the Richmond Agitation Sedation Scale, assessed 5 minutes before and 15, 30, and 60 minutes after the intervention

Secondary Outcome Measures

Name	Time	Method
Minimal documentation system (MIDOS2), a self-constructed scale confidence (0-10, 10 = maximum confidence) and vital signs (heart and respiratory rate, blood pressure), assessed 5 minutes before and 60 minutes after the intervention. Other parameters are the feasibility of the intervention (degree of recruitment, ratio of performed vs. indicated interventions, Number of safety events), assessed during the study period.